[The adult respiratory distress syndrome as a complication of the APSAC treatment of acute myocardial infarct. Apropos a case].
Thrombolytic therapy has shown to be effective in acute myocardial infarction, and its benefits on left ventricular function and later survival are well known. However it is not a therapy free of complications and side effects. Allergic reactions, anafilaxia, hypotension, and several kinds of hemorrhages have been reported. Adult respiratory distress syndrome after streptokinase administration has been also described, and one case, recently communicated, after APSAC therapy. We present the case of a male with acute myocardial infarction who developed adult respiratory distress syndrome after APSAC therapy, with different outcome than the first case published in the literature. Finally, we discussed the mechanisms by means these drugs can produce such a complication.
García González
M J
MJ
Servicio de Cardiología, Hospital Universitario de Canarias, Tenerife.
Bosa Ojeda
F
F
Barragán Acea
A
A
Marrero Rodríguez
F
F
Laynez Cerdeña
I
I
Lara Padrón
A
A
Lacalzada Almeida
J
J
de Armas Trujillo
D
D
D000328:Adult; D016255:Anistreplase / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D012128:Respiratory Distress Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D013997:Time Factors
D016255:Anistreplase
Síndrome de distrés respiratorio del adulto como complicación del tratamiento del infarto agudo de miocardio con APSAC. A propósito de un caso.